These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17413764)

  • 1. The efficiency of anti-activated factor X and anti-activated factor II anticoagulants.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):265-9. PubMed ID: 17413764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin.
    Stief TW
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):633-7. PubMed ID: 17102649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the anti-F10a or anti-F2a generation action of rivaroxaban or dabigatran.
    Stief TW
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):619-21. PubMed ID: 22821003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coagulation factors on extrinsic thrombin generation.
    Stief TW; Wieczerzak A; Renz H
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):105-12. PubMed ID: 17287625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intrinsic coagulation activity assay.
    Stief TW; Otto S; Renz H
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):369-78. PubMed ID: 16788313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of thrombin generation in recalcified plasma.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):751-60. PubMed ID: 17982316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anticoagulant capacity of plasmatic unfractionated heparin decreases at 23 degrees C.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):209-12. PubMed ID: 17287642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extrinsic coagulation activity assay.
    Stief TW; Wieczerzak A; Renz H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):303-18. PubMed ID: 18586682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific determination of plasmatic thrombin activity.
    Stief TW
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the surface on thrombin generation.
    Stief TW
    Int J Lab Hematol; 2008 Aug; 30(4):269-77. PubMed ID: 18665823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of factor IIa inhibitors on the endogenous thrombin potential.
    Beilfuss A; Grandoch M; Wenzel F; Hohlfeld T; Schrör K; Weber AA
    Ther Drug Monit; 2008 Dec; 30(6):740-3. PubMed ID: 18824953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikrein activates prothrombin.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):97-8. PubMed ID: 18160576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
    Oldgren J; Johnston N; Siegbahn A
    Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation by exposure of blood to endotoxin: a simple model to study disseminated intravascular coagulation.
    Stief TW
    Clin Appl Thromb Hemost; 2006 Apr; 12(2):137-61. PubMed ID: 16708116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recalcified coagulation activity.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):447-53. PubMed ID: 18160574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential coagulation inhibitory effect of fondaparinux, enoxaparin and unfractionated heparin in cell models of thrombin generation.
    Ben-Hadj-Khalifa S; Hézard N; Almawi WY; Remy MG; Florent B; Mahjoub T; Nguyen P
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):369-73. PubMed ID: 21577096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombin in plasma by heparin or arginine.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):146-53. PubMed ID: 17456623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.